P09320e4

Abilify is a medication that is classified as an atypical antipsychotic and antidepressant.

This medication is also known as Aripiprazole and it was Approved by the FDA in 2002 for schizophrenia

It is typically prescribed for Mixed Episodes and Acute Manic of Bipolar Disorder and approved for this in 2004.

It was also approved for use in combination with other drugs for Major Depressive Disorder in 2007.

Typical Uses of Abilify:

1.)  Clinical Depression
2.)  Bipolar Disorder
3.)  Schizophrenia

Typical Ages for use:

–  Approved for ages 10 – 17
–  Approved for Adults

The Mechanism of Action:

–  Acts as a D2 partial agonist and 5-HT(1A) Receptor, and like other atypical is a partial agonist of 5-HT(2A) Receptor.
–  14 days are typical for the proper amount of concentration to be found within the plasma

Side Effects are possible as follows:

–  Headache
–  Tiredness
–  Weakness
–  Dizziness
–  Insomnia
–  Shaking
–  Blurred vision

Rarely seen side effects are:

–  Tardive dyskinesia
–  Stroke
–  Blood Sugar Changes
–  Allergic reaction

Drug interactions

  –  Paroxetine
  –  Fluoxetine
  –  Carbamazepine

**  – occasionally dosing may need adjustment with the above medications

–  Alcohol

VN:F [1.9.22_1171]
Rating: 3.5/10 (2 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 2 votes)
Abilify, 3.5 out of 10 based on 2 ratings